Evidence map›Paper›PMID 39595558›Full record

ReviewBiomolecules2024

Familial Pancreatic Cancer Research: Bridging Gaps in Basic Research and Clinical Application.

Suyakarn Archasappawat, Fatimah Al-Musawi, Peiyi Liu, EunJung Lee, Chang-Il Hwang

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Biomolecules, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Suyakarn ArchasappawatDepartment of Microbiology and Molecular Genetics, College of Biological Sciences, University of California, Davis, Davis, CA 95616, USA.
Fatimah Al-MusawiDepartment of Microbiology and Molecular Genetics, College of Biological Sciences, University of California, Davis, Davis, CA 95616, USA.
Peiyi LiuDepartment of Microbiology and Molecular Genetics, College of Biological Sciences, University of California, Davis, Davis, CA 95616, USA.ORCID 0009-0003-6467-7360
EunJung LeeDepartment of Microbiology and Molecular Genetics, College of Biological Sciences, University of California, Davis, Davis, CA 95616, USA.
Chang-Il HwangDepartment of Microbiology and Molecular Genetics, College of Biological Sciences, University of California, Davis, Davis, CA 95616, USA.ORCID 0000-0002-5710-7672

Funding

Staff InvestigatorsP30CA093373 · NCI · UNIVERSITY OF CALIFORNIA DAVIS · PI Laura Marcu · 2002 to 2026
$84.9M
Engrailed-1 and Epigenetic Vulnerabilities in Metastatic Pancreatic CancerR37CA249007 · NCI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI Chang-il Hwang · 2021 to 2026
$2.1M
NCI NIH HHS P30 CA093373NCI NIH HHS R37 CA249007
6 · The paper itself

Abstract

Familial pancreatic cancer (FPC) represents a significant yet underexplored area in pancreatic cancer research. Basic research efforts are notably limited, and when present, they are predominantly centered on the

Indexed as

Carcinoma, Pancreatic DuctalPancreatic NeoplasmsAnimalsBRCA1 ProteinBRCA2 ProteinCarcinomaHumansMiceMutationPoly(ADP-ribose) Polymerase InhibitorsBRCA1 ProteinBRCA1 protein, humanBRCA2 ProteinBRCA2 protein, humanPoly(ADP-ribose) Polymerase InhibitorsBRCA1BRCA2familial pancreatic cancerhomologous recombinationpancreatic ductal adenocarcinomaPARP inhibitor

Identifiers

PMID39595558
PMCPMC11592027

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.